Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is -18.42% as of the fiscal period ended Tuesday, December 31, 2024.
Limited history available
TDAC EBITDA Margin has fewer than three reported periods, so a trend chart would be misleading.
EBITDA MARGIN
-18.42%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
N/A
EBITDA MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Translational Development Acquisition Corp.
Market Cap
$266.50M
EBITDA Margin
-18.42%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$266.29M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$265.95M
EBITDA Margin
27.96%
TTM Avg
24.93%
3Y Avg
21.37%
5Y Avg
24.70%
Market Cap
$267.82M
EBITDA Margin
26.91%
TTM Avg
21.75%
3Y Avg
5.38%
5Y Avg
3.15%
Market Cap
$264.51M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.38M
EBITDA Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Translational Development Acquisition Corp. (TDAC) | $266.50M | -18.42% | N/A | N/A | N/A |
| Thunder Bridge Capital Partners V L (TBCVU)vs › | $266.29M | N/A | N/A | N/A | N/A |
| Hawthorn Bancshares, Inc. (HWBK)vs › | $265.95M | 27.96% | 24.93% | 21.37% | 24.70% |
| Kingstone Companies, Inc. (KINS)vs › | $267.82M | 26.91% | 21.75% | 5.38% | 3.15% |
| LCNB Corp. (LCNB)vs › | $268.25M | 23.20% | 18.20% | 23.18% | 27.24% |
| Oaktree Acquisition Corp. II (OACC)vs › | $264.51M | N/A | N/A | N/A | N/A |
| ProCap Acquisition Corp (PCAP)vs › | $264.47M | N/A | N/A | N/A | N/A |
| Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA)vs › | $264.38M | N/A | N/A | N/A | N/A |
| Soren Acquisition Corp. (SORN)vs › | $263.53M | N/A | N/A | N/A | N/A |
| Cartesian Growth Corp. Iv (CGCF)vs › | $270.05M | N/A | N/A | N/A | N/A |
Gross Margin
0.0%
EBITDA Margin
-18.4%
Operating Margin
0.0%
Net Margin
0.0%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2024-12-31 | -18.42% |
